baber/WOPTO huggingface dataset:
Patent EA-001266-B1 (EA)
Title: Method for rehabilitation of pulmonary tubercular patient
Inventor: KRASNOPEROV ALEXANDR NIKOLAEVI
IPC: A61N5/067
Filed: 1999-12-10
Abstract: 1. A method for rehabilitation of pulmanory tubercular patients, the method relates to phthisiology, comprising use of low intensive laser radiation with simultaneous action of several laser emitters upon the zones of pathological action with simultaneous treating by chemotherapy, characterized in that said method is carried out using low intensive infrared lasers, radiant flux power in impulse 4-8 wt each, non invasive transdermal action on the surface of the chest of a pulmanory tubercular patients in location of 7-8 projections of the affected zones of the breathing organs with monochromatic laser radiation with the impulse frequency 5-50 Hz, wave band 0,8 mμ in combination with wide band infrared radiation in the range of wave band ,86-0,96 mμ and with the impulse radiation 0,6-0,75 mμ in 1 to 3 courses of treatment, consisting of 15 daily visits duration from 5 to 10 min each, the total number of courses and duration of visits are prescribed depending on the age, clinical form of the patient's disease, and continue the treatment until full cease of bacteria secretion and liquidation of destructive processes. 2. The method for rehabilitation of pulmanory tubercular patients as claimed in claim 1, characterized in that for intensifying the rehabilitation process the tubercular patient is subjected to synchronous radiation by 7-8 low intensive infrared lasers covering all locations of the chest affected zones. 3. The method as claimed in claim 1 and 2, characterized in that during the rehabilitation period the tubercular patient is simultaneously administered general somatic course of laser
Patent EA-002659-B1 (EA)
Title: Use 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)etoxy]benzyl]-thiazolidine-2,4-dione for treating hyperglycaemia
Inventor: BUCKINGHAM ROBIN EDWIN
IPC: A61K31/426
Filed: 1998-10-12
Abstract: 1. A use of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]-benzyl]thiazolidine-2,4-dione (Compound (I)) or a tautomeric form thereof or a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate thereof for the treatment of hyperglycaemia in the range of from elevated normal to < 126mg/dl. 2. A method according to Claim 1, wherein the hyperglycaemia is fasting hyperglycaemia. 3. A method according to Claim 2, wherein the hyperglycaemia in the range of from elevated normal to < 126mg/dl is additionally characterized with level <140mg/dl following an oral glucose tolerance test. 4. A method according to Claim 2, wherein the hyperglycaemia in the range of from elevated normal to < 126mg/dl is additionally characterized with levels from <140mg/dl to <200mg/dl following an oral glucose tolerance test. 5. A method according to Claim 1, wherein 2 to 12 mg of Compound (I) is administered per day. 6. A method according to Claim 1, wherein Compound (I) is in the form of compositions adapted for oral administration. 7. A method according to Claim 6, wherein the composition is in unit dosage form.
Patent EA-003786-B1 (EA)
Title: N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases
Inventor: BRIDGES ALEXANDER JAMES
IPC: A61K31/5377
Filed: 1999-09-23
Abstract: 1. N-[4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazoline-6-yl]acrylamide, or the pharmaceutically acceptable salts thereof. 2. A pharmaceutically acceptable composition that comprises a compound of Claim 1. 3. A method of treating cancer, comprising administering to a patient having cancer a therapeutically effective amount of a compound of Claim 1. 4. The method of Claim 3, wherein cancer is the colon cancer. 5. A method of treating or preventing restenosis or atherosclerosis, the method comprising administering to a patient having restenosis or atherosclerosis, or at risk of having restenosis or atherosclerosis, a therapeutically affective amount of a compound of Claim 1. 6. A method of irreversibly inhibiting tyrosine kinases, the method comprising administering to a patient in need of tyrosine kinase inhibition a tyrosine kinase inhibiting amount of a compound of Claim 1. 7. The method of Claim 6, wherein the tyrosine kinase is EGFR, erbB2, erbB4. 8. A method of inhibiting the tyrosine phosphorylation of erbB3 or VEGF secretion comprising administering to a patient in need of the inhibition of tyrosine phosphorylation of erbB3 or VEGF secretion a therapeutically effective amount of a compound of Claim 1. 9. A method of treating psoriasis or endometriosis, the method comprising administering to a patient having psoriasis or endometriosis a therapeutically effective amount of a compound of Claim 1.
Patent EA-004594-B1 (EA)
Title: The method of treating drug resistant mycobacterium tuberculosis
IPC: A61P31/06
Filed: 2001-06-26
Abstract: 1. The method of treating drug-resistant mycobacterial infection in an animal comprising administration to the said animal, Penicillin and isoniazid (INH). 2. The method of claim 1 wherein penicillin is administered simultaneously with INH. 3. The method as claimed in claim 1 wherein penicillin and INH are administered sequentially. 4. The method as claimed in claim 1 to 3 wherein penicillin can be a broad spectrum penicillin or a narrow spectrum penicillin. 5. The method as claimed in claim 1 to 4 wherein penicillin can be any single penicillin or combination of more than one penicillin. 6. The method as claimed in claim 1 to 5 wherein penicillin can have activity against beta-lactamase producing organism. 7. The method as claimed in claim 1 to 4 wherein penicillin can be active against penicillinase producing organisms. 8. The method as claimed in claim 1 to 5 wherein penicillins can be selected from the group of penicillin comprising Benzylpenicillin, Phenoxymethylpenicillin, Propicillin, Clemizole penicillin, Procaine penicillin, Phenethicillin, Hetacillin, Metampicillin, Pivampicillin, Cyclacillin, Epicillin, Pevmecillinam, Apalcillin, Aspoxicillin, Temocillin, Methicillin, Oxacillin, Nafcillin, Ampicillin, Amoxycillin, Carbenicillin, Ticarcillin, Azlocillin, Mezlocillin, Piperacillin, Cloxacillin, Dicloxacillin, Lenampicillin, Bacampicillin, Azidocillin, Talampicillin, Mecillinam, Flucloxacillin, Aztreonam, Imipenem, Meropenem and the like. 9. The method as claimed in claim 1 wherein penicillin can be administered by oral, parenteral or rectal route. 10. The method as claimed in claim 1 wherein penicillin can be administered separately or as a single fixed dose combination.
Patent EA-007103-B1 (EA)
Title: Method and system for accessing information on a network
Inventor: OSAKU TEIZO
IPC: G06F17/30
Filed: 1998-10-27
Abstract: The present invention provides methods and systems for accessing a network URL through a pre-assigned simplified network address, correlating to the URL, and for displaying the home page having the URL as its address. These methods and systems provide easier URL and home page access because persons wanting to access the home page need only input the simplified network address, thereby avoiding the need to know and input the URL character string. The simplified network addresses of the present invention include numbers. Methods are provided for selecting numbers for assignment to URLs. The URL and home page access and display methods of the present invention include: assigning a simplified network address such as a number to a URL, storing the URL and number conversion in a network accessible storage system, inputting the assigned number in a network accessible computer, communicating the inputted number to the storage system, converting the number to the URL, retrieving the home page corresponding to the URL and displaying the home page on the computer. Additionally, the invention provides methods for use in message passing operating systems wherein system level messages to specific objects are intercepted, creating an alias message.
Patent EA-008610-B1 (EA)
Title: Hfa-suspension formulation of an anhydrate
Inventor: SCHMELZER CHRISTEL
IPC: A61K31/439
Filed: 2003-03-20
Abstract: The invention relates to propellant formulations containing suspensions of a crystalline anhydrate of (1alpha,2beta,4beta,5alpha,7beta)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0]nonane bromide.
Patent EA-012367-B1 (EA)
Title: Composition and method for removal capsaicin from bodily surface, a kit therefor and method for treating pain
Inventor: ANGEL ARTURO
IPC: A61K9/14
Filed: 2003-09-05
Abstract: The invention provides compositions, methods for the removal of capsaicin or a capsaicin analog and also kits and a method for treating pain based on said composition. Such compositions, kits and methods find application in medicine and animal health.
Patent EA-008831-B1 (EA)
Title: Glp-1 analog fusion proteins
Inventor: GLAESNER WOLFGANG
IPC: C07K14/50
Filed: 2004-06-10
Abstract: The invention provides specific GLP-1 analogs fused to specific IgG4-Fc derivatives. These fusion proteins have an increased half-life, decreased immunogenicity, and reduce effector activity. The fusion proteins are useful in treating diabetes, obesity, irritable bowel syndrome and other conditions that would be benefited by lowering plasma glucose, inhibiting gastric and/or intestinal motility and inhibiting gastric and/or intestinal emptying, or inhibiting food intake.
Patent EA-009622-B1 (EA)
Title: Weed control in joints of concrete blocks and other paving stone
Inventor: SONDERBERG FREDERIKSEN JENS
IPC: E01H11/00
Filed: 2004-09-17
Abstract: Joint filing sands for concrete and other paving stone arc known to act as substrate for weed growth. The present invention drastically reduces the necessary weed control work by making the joint filling sand a hostile substrate for plant and fungus growth by the use of environmentally acceptable slow release mineral additive. The additive having similar grain size distribution and with similar mechanical and rheological properties forms an integral part of the joint filling sand. The specific gravity of the additive is lower than quartz sand imparting a tendency for the additive to migrate towards the top part of the joint. The additive leads to pore waters being rich in sodium and at high pH, both qualities being maintained over long periods of time. The mixture of additive and sand can be handled and applied using conventional laying techniques and equipment, observing usual precautions as used for mortar or cement mixes with sand. In the environment, reaction with COin the air or in the soil porosity will inactivate the causticity, yielding harmless carbonate salts.
Patent EA-010261-B1 (EA)
Title: Imidazoryridine-derivatives as inductible no-synthase inhibitors
Inventor: FUCHSS THOMAS
IPC: A61P29/00
Filed: 2004-09-30
Abstract: There proposed the compounds of formula (I)in which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.
Patent EA-010038-B1 (EA)
Title: Molecular sieve catalyst composition, its making and use in conversion processes
Inventor: CHANG YUN-FENG
IPC: B01J29/06
Filed: 2004-08-16
Abstract: This invention provides methods of making molecular sieve catalyst particles, molecular sieve slurries that can be used in such methods, molecular sieve catalyst compositions and their use in catalytic hydrocarbon conversion processes. In one of its aspects, the invention provides a method of making molecular sieve catalyst particles, the method comprising the steps of: a) providing a solution or suspension of an aluminum-containing inorganic oxide precursor in a liquid medium; b) combining the solution or suspension of aluminum-containing inorganic oxide precursor with a molecular sieve, and optionally other formulating agents, to form a catalyst formulation slurry; c) aging the catalyst formulation slurry to generate in said slurry a percentage, or increase in said slurry the existing percentage, of aluminum atoms of the aluminum-containing precursor in the form of oligomers having a sharp peak at 62-63 ppm in a spectrum NMRAl; and d) forming molecular sieve catalyst particles from the catalyst formulation slurry. The catalyst compositions obtained by the methods of the present invention have improved attrition resistance, and are particularly useful in hydrocarbon conversion processes.
Patent EA-010957-B1 (EA)
Title: Remotely instantly coupon–reloadable prepaid payment card
Inventor: ZORMATI ALEXANDRE SAM
IPC: G07F7/08
Filed: 2004-12-08
Abstract: The invention relates to reloadable payment cards, in particular to a method for paying a transaction carried out with a merchant by a prepaid payment card delivered by a financial intermediary comprising reloading steps for modifying information concerning the available balance of a bankcard owner on a management computer consisting in reloading by means of prepaid coupon to which a single identification number is assigned and a predefined sum is predefined, wherein said management server contains a data base of single coupon numbers and the validity state and value corresponding thereto. The reloading steps consist in transmitting said coupon identifier and said bankcard identifier to the management server, in verifying the validity of the received coupon identifier by said management server, in determining the denomination of a sum assigned to the coupon, in modifying the validity state of a consumed coupon and in updating the account balance of said bankcard.
Patent EA-013520-B1 (EA)
Title: Hiv protease inhibitors
Inventor: EKEGREN JENNY
IPC: A61K31/17
Filed: 2006-02-09
Abstract: Compounds of the formula (I):
Patent EA-014100-B1 (EA)
Title: 2,4-diaminopyridine derivatives, pharmaceutical composition, medicament based thereon for treating and preventing diseases and disorders caused by nmda-receptors hyperactivation and/or as stimulators of cognitive function and method of treatment
Inventor: GRANIK VLADIMIR GRIGORIEVICH
IPC: A61K31/44
Filed: 2008-02-21
Abstract: The invention relates to novel 2,4-diaminopyridines, pharmaceutically acceptable salts and/or solvates thereof, compositions, medicaments comprising novel 2,4-aminopyridine derivatives and use thereof as NMDA receptors blockers, and also as stimulators of cognitive functions. The novel derivatives combine properties of highly-affine antagonist of NMDA receptors with properties of medium inhibitors of acetylcholinesterase and properties highly affine agonists of nicotine cholino receptors and sympathomimetics, stimulating their complex normalizing action on a disbalance of several neurotransmiting systems, including glutamatergic, cholinergic and adrenergic systems not displaying undesirable side effects earlier expressed in known NMDA antagonists. They do not only cause disorders of mental capacities, attention and memory typical for known NMDA –receptor antagonists, but on the contrary, can be suitable for treating and preventing some diseases or disorders associated with disorders of cognitive functions and ability to teaching. The invention also relates to a method of treating or preventing diseases and disorders associated with increased activation of glutamatergic system and/or affection of intellectually-mnestic functions.
Patent EA-017752-B1 (EA)
Title: Use of l-carnitine for the preparation of a medicament in the form of eye-drops for treating corneal disease
Inventor: KOVERECH ALEARDO
IPC: A61K31/185
Filed: 2007-11-21
Abstract: Use of L-carnitine or a pharmaceutically acceptable salt thereof, for the preparation of an opthalmic physiological supplement or medicament in the form of eye-drops, for the treatment of corneal oedema.
Patent EA-018647-B1 (EA)
Title: Herbicidal compositions comprising pyroxasulfone
Inventor: SIEVERNICH BERND
IPC: A01N33/18
Filed: 2009-03-10
Abstract: The present invention relates to herbicidally active compositions, comprising: a) herbicide A which is 3-[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)pyrazol-4-ylmethylsulfonyl]-4,5-dihydro-5,5-dimethyl-1,2-oxazole; and b) herbicide B which comprises pendimethalin. The invention also relates to a herbicidal composition comprising: a) herbicide A which is 3-[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)pyrazol-4-ylmethylsulfonyl]-4,5-dihydro-5,5-dimethyl-1,2-oxazole; and b) herbicide B which comprises pendimethalin; and c) herbicide D selected from the group consisting of dimethenamid, dimethenamid-P, flufenacet, metribuzin, flupyrsulfuron, picolinafen and prosulfocarb. The invention furthermore relates to the use of a composition as defined herein for controlling undesirable vegetation in crops. When using the compositions of the invention for this purpose the herbicide A, herbicide B and the at least one herbicide D can be applied simultaneously or in succession in crops, where undesirable vegetation may occur.
Patent EA-017367-B1 (EA)
Title: Household appliance comprising a first air conduit and a heat pump
Inventor: BALERDI AZPILICUETA PILAR
IPC: D06F58/24
Filed: 2008-11-26
Abstract: The invention relates to a household appliance 1 comprising a housing 2, a drying chamber 3 for drying wet articles 6 therein, a first air conduit 7 for guiding process air drawn into said housing 2 to dry the articles 6 and a heat pump 12, 13, 14, 15, 16, 17, said heat pump 12, 13, 14, 15, 16, 17 comprising a heat sink 14 for transferring heat into said heat pump 12, 13, 14, 15, 16, 17, a heat source 13 coupled to said first air conduit 7 for transferring heat from said heat pump 12, 13, 14, 15, 16, 17 into the process air, and a heat transfer device 12, 15, 16, 17 for transferring heat from said heat sink 14 to said heat source 13. Said heat sink 14 is coupled to a second air conduit 18 for guiding secondary air drawn into said housing 2, for transferring heat from the secondary air into said heat pump 12, 13, 14, 15, 16, 17.
Patent EA-021119-B1 (EA)
Title: Carboxamide compounds for the treatment of metabolic disorders
Inventor: YU JIAXIN
IPC: C07D487/08
Filed: 2009-04-22
Abstract: Disclosed are carboxamide compounds or pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions comprising said compounds and methods of use. One embodiment is a compound having the structure (I) in which R, R, R, R, D, J, Z, y, w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.
Patent EA-018749-B1 (EA)
Title: Method for treating nickel laterite ore
Inventor: RUONALA MIKKO
IPC: C22B23/00
Filed: 2009-10-29
Abstract: The invention relates to a method for processing laterite ores so that the metals contained in the laterites are turned into water-soluble form for the recovery of valuable metals, such as nickel and cobalt. Different types of nickel laterites are processed at the same time without being separated according to their iron and/or magnesium content. When laterites are pretreated with concentrated mineral acid so that the metals contained in the laterites react to form water-soluble salts, the silicates contained in the laterites are partially decomposed and postleaching liquid-solid separation becomes easier than it was previously. According to the method, the water vapour generated in the ore and acid reaction stage is utilised in ore drying and the unreacted mineral acid is recycled to the front end of the process.
Patent EA-026108-B1 (EA)
Title: Composition comprising an encapsulated pesticide and method for the pesticidal treatment of crops
Inventor: BRAHM LUTZ
IPC: A01P3/00
Filed: 2010-03-12
Abstract: The present invention is related to a composition comprising an encapsulated pesticide, wherein: a. the encapsulation material of the encapsulated pesticide comprises polyisocyanate and α,ω-diamine of the formula HN-(CH)-NH, wherein n is an integer from 2 to 6 in polymerized form; and b. in the core of the capsules at least 80% of the pesticide is dissolved in an organic solvent at 25°C, and wherein the composition comprises 50 to 150 g/l polyisocyanate and 1 to 10 g/l α,ω-diamine. The invention is also related to a method for the pesticidal treatment of crops which have a final growth height of at least 140 cm, comprising the treatment of the crop with said composition at a growth height of the crop of higher than 30 cm and less than 120 cm.
Patent EA-025362-B1 (EA)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: A23K10/32
Filed: 2007-10-26
Abstract: Provided is processing biomass (e.g. plant biomass, animal biomass and municipal waste biomass) to produce useful products, such as fuels. Disclosed are systems that can use feedstock materials, such as cellulosic and/or lignocellulosic materials, to produce ethanol and/or butanol, e.g., by fermentation.
Patent EA-021024-B1 (EA)
Title: Cosmetic foam
Inventor: ABRAM ALBERT ZORKO
IPC: A61K36/886
Filed: 2010-09-28
Abstract: The present invention provides aerosol foams comprising Aloe vera. In particular, the foams comprise: (a) Aloe vera, (b) a surfactant and (c) a propellant. The foams may further comprise one or more of the group consisting of an α-hydroxy acid, a β-hydroxy acid, a humectant, a thickening agent, a dermatologically acceptable excipient, and mixtures thereof.
Patent EA-020528-B1 (EA)
Title: Macrocycles as factor xia inhibitors
Inventor: CORTE JAMES R
IPC: C07D498/08
Filed: 2011-02-10
Abstract: The present invention provides compounds of Formula (I)or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of factor XIa and plasma kallikrein and can be used for treating thromboembolic and/or inflammatory disorders.
Patent EA-024237-B1 (EA)
Title: Method for the chemical treatment of starch to be applied to sheets of paper
Inventor: GRACIA GRANDIA ORIOL
IPC: D21H21/14
Filed: 2009-10-02
Abstract: The method of the invention aims to increase starch retention in sheets of paper in order to reduce operating costs and enhance the physical properties of the paper. For this purpose, the method comprises the addition of metered trivalent cation salts to the slurry or during the method for obtaining powdered starch or by mixing a percentage of powdered trivalent salts with the starch powder, in order to obtain a salt solution in the slurry so that said salts dissolve during the dispersion of the slurry in the paper sheet production method. Optionally, in addition to said salts, it is also possible to use organic polymers such as polyacrylamides, polyvinylamides and polyDADMACs.